Vitamin D enhances erlotinib response in EGFR-mutant non-small cell lung cancer

被引:0
|
作者
Shaurova, Tatiana
Shoemaker, Suzanne F.
Hershberger, Pamela A.
机构
关键词
D O I
10.1158/1538-7445.AM2016-4674
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4674
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Pulsed dosing of erlotinib for central nervous system (CNS) progression in EGFR-mutant non-small cell lung cancer (NSCLC)
    Jackman, David Michael
    Mach, Stacy L.
    Heng, Jennifer C.
    Rabin, Michael S.
    Barbie, David Allen
    Gandhi, Leena
    Marcoux, J. Paul
    Costa, Daniel Botelho
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Transcriptomic Heterogeneity of EGFR-Mutant Non-Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer
    Oh, Songji
    Koh, Jaemoon
    Kim, Tae Min
    Kim, Soyeon
    Youk, Jeonghwan
    Kim, Miso
    Keam, Bhumsuk
    Jeon, Yoon Kyung
    Ku, Ja-Lok
    Kim, Dong-Wan
    Chung, Doo Hyun
    Heo, Dae Seog
    CLINICAL CANCER RESEARCH, 2024, 30 (20) : 4729 - 4742
  • [33] Remarkable response to dacomitinib in a patient with leptomeningeal carcinomatosis due to EGFR-mutant non-small cell lung cancer
    Mizusaki, Shun
    Otsubo, Kohei
    Ninomiya, Toshifumi
    Arimura, Hidenobu
    Tsuchiya-Kawano, Yuko
    Inoue, Koji
    THORACIC CANCER, 2021, 12 (01) : 114 - 116
  • [34] Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer
    Lantermann, Alexandra B.
    Chen, Dongshu
    McCutcheon, Kaitlin
    Hoffman, Greg
    Frias, Elizabeth
    Ruddy, David
    Rakiec, Daniel
    Korn, Joshua
    McAllister, Gregory
    Stegmeier, Frank
    Meyer, Matthew J.
    Sharma, Sreenath V.
    CANCER RESEARCH, 2015, 75 (22) : 4937 - 4948
  • [35] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Gen, Soei
    Tanaka, Ichidai
    Morise, Masahiro
    Koyama, Junji
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Hashimoto, Naozumi
    BMC CANCER, 2022, 22 (01)
  • [36] Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer
    Chen, Lanyi Nora
    Ma, Xin
    Herzberg, Benjamin
    Henick, Brian S.
    Biswas, Anup K.
    Acharyya, Swarnali
    Shu, Catherine A.
    ONCOLOGIST, 2024,
  • [37] Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non-Small Cell Lung Cancer Cells
    Gao, Wen
    Wang, Michael
    Wang, Li
    Lu, Haibo
    Wu, Shuhong
    Dai, Bingbing
    Ou, Zhishuo
    Zhang, Liang
    Heymach, John V.
    Gold, Kathryn A.
    Minna, John
    Roth, Jack A.
    Hofstetter, Wayne L.
    Swisher, Stephen G.
    Fang, Bingliang
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (09):
  • [38] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
    Soei Gen
    Ichidai Tanaka
    Masahiro Morise
    Junji Koyama
    Yuta Kodama
    Akira Matsui
    Ayako Miyazawa
    Tetsunari Hase
    Yoshitaka Hibino
    Toshihiko Yokoyama
    Tomoki Kimura
    Norio Yoshida
    Mitsuo Sato
    Naozumi Hashimoto
    BMC Cancer, 22
  • [39] Effect of BIM and mTOR expression on clinical outcome to erlotinib in EGFR-mutant non-small cell lung cancer (NSCLC) patients (p)
    Karachaliou, Niki
    Drozdowskyj, Ana
    Gimenez Capitan, Ana
    Cardona Zorrilla, Andres Felipe
    Gervais, Radj
    Massuti, Bartomeu
    Moran, Teresa
    Majem, Margarita
    Felip, Enriqueta
    Carcereny Costa, Enric
    Garcia Campeio, Rosario
    Viteri Ramirez, Santiago
    Morales-Espinosa, Daniela
    Verlicchi, Alberto
    Crisetti, Elisabetta
    Chaib, Imane
    Luis Ramirez, Jose
    Ma, Patrick C.
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impact on Operable EGFR-Mutant Non-Small Cell Lung Cancer
    Ahn, Beung-Chul
    Park, Charny
    Kim, Moon Soo
    Lee, Jong Mog
    Choi, Jin Ho
    Kim, Hyae Young
    Lee, Geon Kook
    Yu, Namhee
    Lee, Youngjoo
    Han, Ji-Youn
    CANCER RESEARCH AND TREATMENT, 2024, 56 (01): : 70 - 80